Serge Bodart of IDDI provides insight on the pharma and biopharma trends impacting CROs, outsourcing in today’s market, and advances in clinical research.
For Rosa's PhysioPD research services, which will provide Chugai with a competitive research and development advantage across multiple therapeutic areas